Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows a revision label update from v3.3.3 to v3.3.4, with no impact on study details or user-facing content. This is a minor technical update to the page version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:45:26.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new Locations section appears listing sites in Nevada, New Jersey, and South Carolina. The older state-specific location subsections were removed, and the footer’s HHS Vulnerability Disclosure link was deleted.
    Difference
    0.3%
    Check dated 2025-12-23T20:39:49.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:51:50.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The banner about a lapse in government funding has been removed from the page. The study details and links remain intact.
    Difference
    0.3%
    Check dated 2025-11-18T07:23:21.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The two screenshots show no changes to core study information; only layout/UI presentation differs. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:30:14.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T07:55:38.000Z thumbnail image

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.